7 Analysts Assess Emergent BioSolutions: What You Need To Know
7 Analysts Assess Emergent BioSolutions: What You Need To Know
7位分析師評估 Emergent BioSolutions:你需要知道的一切
In the last three months, 7 analysts have published ratings on Emergent BioSolutions (NYSE:EBS), offering a diverse range of perspectives from bullish to bearish.
在過去三個月中,共有7位分析師對Emergent BioSolutions (NYSE:EBS)發表了評級,提供了從看好到看淡的各種不同觀點。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述,爲了全面了解過去30天的情緒變化並與前幾個月進行比較,提供了深入的見解。
Analysts have recently evaluated Emergent BioSolutions and provided 12-month price targets. The average target is $8.0, accompanied by a high estimate of $8.00 and a low estimate of $8.00. This upward trend is evident, with the current average reflecting a 5.68% increase from the previous average price...
分析師最近對Emergent BioSolutions進行了評估並提供了12個月的價格...
登入免費觀看全文
登入/註冊